4D MOLECULAR THERAPEUTICS IN (FDMT) Stock News
NASDAQ:FDMT - US35104E1001 - Common Stock
7.27 USD
+0.66 (+9.98%)
7.3499 USD
+0.08 (+1.1%)
FDMT Latest News, Press Relases and Analysis
All
Press Releases
4 days ago - By: 4D Molecular Therapeutics, Inc.
4 days ago - By: 4D Molecular Therapeutics, Inc.
12 days ago - By: 4D Molecular Therapeutics, Inc.
12 days ago - By: 4D Molecular Therapeutics, Inc.
22 days ago - By: 4D Molecular Therapeutics, Inc.
22 days ago - By: 4D Molecular Therapeutics, Inc.
25 days ago - By: Zacks Investment Research - Mentions: SPRY
26 days ago - By: The Motley Fool
26 days ago - By: 4D Molecular Therapeutics, Inc.
26 days ago - By: 4D Molecular Therapeutics, Inc.
a month ago - By: 4D Molecular Therapeutics, Inc.
a month ago - By: 4D Molecular Therapeutics, Inc.
a month ago - By: 4D Molecular Therapeutics, Inc.
a month ago - By: 4D Molecular Therapeutics, Inc.
a month ago - By: 4D Molecular Therapeutics, Inc.
2 months ago - By: 4D Molecular Therapeutics, Inc.
2 months ago - By: 4D Molecular Therapeutics, Inc.
2 months ago - By: 4D Molecular Therapeutics, Inc.
2 months ago - By: 4D Molecular Therapeutics, Inc.
3 months ago - By: 4D Molecular Therapeutics, Inc.
3 months ago - By: 4D Molecular Therapeutics, Inc.
4 months ago - By: 4D Molecular Therapeutics, Inc.
4 months ago - By: 4D Molecular Therapeutics, Inc.
4 months ago - By: Zacks Investment Research - Mentions: VRCA
